February 20, 2024
September 22, 2022 -Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional). See NOFO RFA-HG-22-027.
National Human Genome Research Institute (NHGRI)
This notice is to alert potential applicants to the early expiration of Notice of Funding Opportunity (NOFO) RFA-HG-22-027 "Diversity Centers for Genome Research (UG3/UH3)". Effective immediately, the final receipt date for this NOFO has been canceled. This NOFO will expire February 20, 2024.
The following section of RFA-HG-22-027 has therefore been modified:
Currently Reads:
Part 1. Overview Information
Key Dates
Application Due Date(s) |
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review | March 2023; January 2024; January 2025 |
Advisory Council Review | May 2023; February 2024; February 2025 |
Expiration Date | June 25, 2024 |
Modified to Read (key change shown in bold italics to indicate early expiration and removal of remaining receipt dates):
Part 1. Overview Information
Key Dates
Application Due Date(s) |
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review | March 2023; January 2024 |
Advisory Council Review | May 2023; February 2024 |
Expiration Date | February 20, 2024 |
All other aspects of this NOFO remain unchanged.
Please direct all inquiries to:
Ebony B. Madden, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-503-5620
Email: [email protected]